These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30391757)

  • 1. Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.
    Okuma Y; Wake H; Teshigawara K; Takahashi Y; Hishikawa T; Yasuhara T; Mori S; Takahashi HK; Date I; Nishibori M
    World Neurosurg; 2019 Feb; 122():e864-e871. PubMed ID: 30391757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-high mobility group box-1 antibody therapy for traumatic brain injury.
    Okuma Y; Liu K; Wake H; Zhang J; Maruo T; Date I; Yoshino T; Ohtsuka A; Otani N; Tomura S; Shima K; Yamamoto Y; Yamamoto H; Takahashi HK; Mori S; Nishibori M
    Ann Neurol; 2012 Sep; 72(3):373-84. PubMed ID: 22915134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-high mobility group box-1 (HMGB1) antibody inhibits hemorrhage-induced brain injury and improved neurological deficits in rats.
    Wang D; Liu K; Wake H; Teshigawara K; Mori S; Nishibori M
    Sci Rep; 2017 Apr; 7():46243. PubMed ID: 28393932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB1 a-Box Reverses Brain Edema and Deterioration of Neurological Function in a Traumatic Brain Injury Mouse Model.
    Yang L; Wang F; Yang L; Yuan Y; Chen Y; Zhang G; Fan Z
    Cell Physiol Biochem; 2018; 46(6):2532-2542. PubMed ID: 29742510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
    Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
    J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
    Zhang J; Takahashi HK; Liu K; Wake H; Liu R; Maruo T; Date I; Yoshino T; Ohtsuka A; Mori S; Nishibori M
    Stroke; 2011 May; 42(5):1420-8. PubMed ID: 21474801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HMGB1 mediates neuroprotection of traumatic brain injury by modulating the microglia/macrophage polarization.
    Gao T; Chen Z; Chen H; Yuan H; Wang Y; Peng X; Wei C; Yang J; Xu C
    Biochem Biophys Res Commun; 2018 Feb; 497(1):430-436. PubMed ID: 29448108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minocycline Attenuates High Mobility Group Box 1 Translocation, Microglial Activation, and Thalamic Neurodegeneration after Traumatic Brain Injury in Post-Natal Day 17 Rats.
    Simon DW; Aneja RK; Alexander H; Bell MJ; Bayır H; Kochanek PM; Clark RSB
    J Neurotrauma; 2018 Jan; 35(1):130-138. PubMed ID: 28699371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Benefit on Brain Edema, Blood-Brain Barrier Permeability, or Cognitive Outcome in Global Inducible High Mobility Group Box 1 Knockout Mice Despite Tissue Sparing after Experimental Traumatic Brain Injury.
    Aneja RK; Alcamo AM; Cummings J; Vagni V; Feldman K; Wang Q; Dixon CE; Billiar TR; Kochanek PM
    J Neurotrauma; 2019 Jan; 36(2):360-369. PubMed ID: 30045665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.
    Li S; Eisenstadt R; Kumasaka K; Johnson VE; Marks J; Nagata K; Browne KD; Smith DH; Pascual JL
    J Trauma Acute Care Surg; 2016 Mar; 80(3):381-7; discussion 387-9. PubMed ID: 26670109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HMGB1 monoclonal antibody therapy for a wide range of CNS and PNS diseases.
    Nishibori M; Mori S; Takahashi HK
    J Pharmacol Sci; 2019 May; 140(1):94-101. PubMed ID: 31105025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-high mobility group box-1 antibody therapy for traumatic brain injury].
    Okuma Y; Date I; Nishibori M
    Yakugaku Zasshi; 2014; 134(6):701-5. PubMed ID: 24882644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats.
    Haruma J; Teshigawara K; Hishikawa T; Wang D; Liu K; Wake H; Mori S; Takahashi HK; Sugiu K; Date I; Nishibori M
    Sci Rep; 2016 Nov; 6():37755. PubMed ID: 27883038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
    Okuma Y; Liu K; Wake H; Liu R; Nishimura Y; Hui Z; Teshigawara K; Haruma J; Yamamoto Y; Yamamoto H; Date I; Takahashi HK; Mori S; Nishibori M
    Neuropharmacology; 2014 Oct; 85():18-26. PubMed ID: 24859607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats.
    Zhou Y; Li Y; Mu T
    Biol Pharm Bull; 2015; 38(8):1150-60. PubMed ID: 26040987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGB1 mediates cognitive impairment caused by the NLRP3 inflammasome in the late stage of traumatic brain injury.
    Tan SW; Zhao Y; Li P; Ning YL; Huang ZZ; Yang N; Liu D; Zhou YG
    J Neuroinflammation; 2021 Oct; 18(1):241. PubMed ID: 34666797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease.
    Sasaki T; Liu K; Agari T; Yasuhara T; Morimoto J; Okazaki M; Takeuchi H; Toyoshima A; Sasada S; Shinko A; Kondo A; Kameda M; Miyazaki I; Asanuma M; Borlongan CV; Nishibori M; Date I
    Exp Neurol; 2016 Jan; 275 Pt 1():220-31. PubMed ID: 26555088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Previous physical exercise alters the hepatic profile of oxidative-inflammatory status and limits the secondary brain damage induced by severe traumatic brain injury in rats.
    de Castro MRT; Ferreira APO; Busanello GL; da Silva LRH; da Silveira Junior MEP; Fiorin FDS; Arrifano G; Crespo-López ME; Barcelos RP; Cuevas MJ; Bresciani G; González-Gallego J; Fighera MR; Royes LFF
    J Physiol; 2017 Sep; 595(17):6023-6044. PubMed ID: 28726269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.
    Liu K; Mori S; Takahashi HK; Tomono Y; Wake H; Kanke T; Sato Y; Hiraga N; Adachi N; Yoshino T; Nishibori M
    FASEB J; 2007 Dec; 21(14):3904-16. PubMed ID: 17628015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences.
    Webster KM; Shultz SR; Ozturk E; Dill LK; Sun M; Casillas-Espinosa P; Jones NC; Crack PJ; O'Brien TJ; Semple BD
    Exp Neurol; 2019 Oct; 320():112979. PubMed ID: 31229637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.